1
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
Condition(s):Mantle Cell LymphomaLast Updated:November 12, 2021Not yet recruiting
Lymphoma, Mantle-Cell: 1157 Clinical Trials, Page 1 of 116
Hide Studies Not Open or Pending
2
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
Condition(s):MCL; Mantle Cell LymphomaLast Updated:February 14, 2022Recruiting
3
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
Condition(s):Lymphoma, Mantle-CellLast Updated:June 28, 2022Recruiting
4
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
Condition(s):Lymphoma, Mantle-CellLast Updated:July 20, 2022Recruiting
5
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:March 18, 2021Recruiting
6
Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:February 5, 2020Recruiting
7
Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
Condition(s):Mantle Cell Lymphoma; LymphomaLast Updated:December 6, 2012Withdrawn
8
Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma
Condition(s):Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaLast Updated:July 11, 2022Recruiting
9
Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
Condition(s):Mantle Cell LymphomaLast Updated:April 24, 2014Completed
10
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
Condition(s):Mantle Cell LymphomaLast Updated:March 18, 2020Unknown status